Jump to:

Anne Landman's Collection

Report P 0500/3068 Skin Tumorigenicity of Mainstream and Sidestream Whole Smoke Condensate of Standard Reference Cigarette 2R1, 80-Week Dermal Application Study with CD1( ICR)BR and B6C3F1 Mice

Date: 26 Oct 1987
Length: 502 pages
2026051118-2026051619
Jump To Images
snapshot_pm 2026051118-2026051619

Abstract

This 502-page scientific report was done at INBIFO, Philip Morris's biological research lab in Europe, and was sent to Ragnar Rylander, a scientist who worked on contract for PM. It is an extensive report on mouse skin painting tests done to determine the carcinogenicity of secondhand (sidestream or "SS") smoke compared with that of mainstream ("MS") smoke. For the test, solids (or "condensate)" were derived from the particulate matter in both mainstream and sidestream smoke and painted onto the skin of 2,625 mice over an 80-week period to gauge the biological reaction. On page 12, Bates No. 2026051129, under "Condensates," the report states that

"The concentrations of the nitrosamines NNN, NATB, NNK, NAB, NPY, and DMNA were between 0.01 and 1.9 milligrams/liter for [mainstream smoke]and between 0.08 and 6.1 milligrams/liter for [sidestream smoke]. The main differences between [mainstream] and [sidestream smoke] were the higher concentrations: of NNK, NPY, and DMNA for [sidestream]."

It also states that,

"The sum of all PAH [polycyclic aromatic hydrocarbons] were 5-fold higher for [sidestream smoke] than for [mainstream smoke]."

and, on page 14, (Bates No. 2026051131) it states that "The number of mice with signs of intoxication was higher in the [sidestream] than in [mainstream] treated groups."

It also states that:

"The comparison of the mortality of [mainstream] and [sidestream] treated mice showed a statistically significantly higher mortality in the [sidestream]treated groups. This is considered to be biologically relevant."

The "Conclusions" section on page 22 (Bates No.2026051139) states that Sidestream Whole Smoke Condensate collected with an impaction trap (SWSC-I) showed 2 to 6 times higher skin tumorigenicity than Mainstream Whole Smoke Condensate collected in the same manner (MWSC-I). Here is the quote:

"SWSC-I assayed for complete tumorigenic activity, i. e., without DMBA pretreatment, showed a 2- to 6-fold higher skin tumorigenicity than MWSC-I."

The section entitled "Mortality" on Page 14 (Bates No. 2026051131) states that,

"The comparison of the mortality of the [mainstream] and [sidestream] treated CD1 and B6C3FI mice showed a statistically significantly higher mortality in the [sidestream] treated groups. This is considered to be biological relevant."

On Page 17 (Bates No. 2026051134), a section entitled "Skin Irritations" states,

"The comparison of skin irritations in [mainstream] and [sidestream] treated CD1 mice showed a statistically significantly higher number of mice with skin irritations in the [sidestream] treated groups. This is considered to be biologically relevant."

On Page 21 (Bates No. 2026051138) a section describing "Pathological Findings" states that,

"The relative skin tumor rate (b), was statistically significantly higher in

(1) [Sidestream treated mice] without and with DMBA pretreatment than in [mainstream treated mice] without and with DMBA pretreatment...These effects are considered to be biologically relevant."

NOTE: Some of the mice were pre-treated with an "initiator" (DMBA), a chemical that was believed to help tumors start forming, but which does not to promote them once they are formed.

The report, dated 26 October 1987, seems to show that Philip Morris had done biological testing on secondhand smoke and found that secondhand smoke was more biologically active than mainstream smoke.

Fields

Notes

Page 7 of the document (Bates No. 2026051124) contains a glossary of abbreviations which is very helpful. This document was used as a Trial Exhibit in Minnesota's case against the industry.

Quotes

ABBREVIATIONS

DBMA - 7,12-dimethylbenz(a)anthracene (a tumor initiator used in pretreating some mice) MSW - Mainstream smoke SS - Sidestream smoke WSC - Whole smoke condensate MWSC-C - Mainstream whole smoke condensate collected with cool trap MWSC-I - Mainstream whole smoke condensate collected with impaction trap SWSC - Sidstream whole smoke condensate SWSC-I - Sidestream whole smoke condensate collection with impaction trap

[From Page 21, 2026051138]

The relative skin tumor rate (b), was statistically significantly higher in (1) SWSC-I without and with DMBA pretreatment than in MWSC-I without and with DMBA pretetreatment...These effects are considered to be biologically relevant.

[From Page 22, 2026051139

Conclusions...

...From the results obtained in the present study, the following is concluded for the skin tumorigenicity, i. e., tumor probability, tumor multiplicity, and malignancy of WSC-I of the standard refer- ence cigarette type 2RI: (

I) SWSC-I assayed for complete tumorigenic activity, i. e., without DMBA pretreatment, showed a 2- to 6- fold higher skin tumorigenicity than MWSC-I. SWSC-I with DMBA pretreatment showed a 2- to 3-fold higher skin tumorigenicity than MWSC-I with DMBA pretreatment indicating a higher promoting activity of the SWSC-I;

[From Page 25, 2026051142]

Laboratory studies can contribute to a better understanding of the factors and mechanisms involved in the induction of disease by environmental agents. There have been numerous bioassays conducted on mainstream smoke (MS). In examining the effects of MS, many research workers have used condensates of the smoke painted on the shaved skin of mice. This contrasts with the human exposure that occurs mainly in the respiratory tract. Skin painting with WSC serves as a model for skin tumorigenicity of tobacco smoke. Nonetheless, these skin painting studies have been useful in examining the carcinogenicity of different tobacco constituents and thus increases knowledge of the actions of MS. Similar skin painting work has not been sufficiently done with sidestream smoke (SS) condensate and would be of value for assessing the differential tumorigenicity of SS condensate and MS condensate. The burning of tobacco products leads to the formation of MS and SS. MS from cigarettes is generated during puff-drawing in the burning cone and hot zones. It travels through the tobacco column and exits from the mouthpiece. SS is formed, in between puff-drawing and is emitted freely from the smouldering tobacco product into the ambient air, and vapor phase components diffuse through the cigarette paper (a). SS is known to have a different composition than MS (see TABLES A and B) in its vapor phase as well as in its particulate phase. It was found that the level of carbon monoxide, carbon dioxide, pyridine, ammonia, nitrogen oxides, nitrosamines, phenols, amines, polycyclic aromatic hydrocarbons such as benzo(a)pyrene and benz(a)ianthracene was much higher in SS than in MS...

Company
Philip Morris
Author
Gerstenberg, B. (Food chemist, INBIFO, c. 1987)
Kuhn, D. (Study Director (mouse skin painting) INBIFO c. 1987)
Romer, Ewald (Quality Assurance Biologist, INBIFO, c. 1987)
Teredesai, A. (Pathologist, INBIFO, c. 1987)
Tewes, F. (Biologist at INBIFO c. 1987)
Thomas, C.
Recipient
Rylander, Ragnar, M.D. (PM contractor, Environmental Hygienist, U of Gothenburg)
Professor of Environmental Hygiene, University of Gothenburg, Sweden. Worked on contract to Philip Morris overseeing biological laboratory work being performed at INBIFO, PM's biological labs in Cologne, Germany. PM paid Rylander $150,000 per year (salary determined from Bliley PM doc 2022850392, from 1992)
Region
Switzerland
Type
SCRT, REPORT, SCIENTIFIC
BIBL, BIBLIOGRAPHY
CHAR, CHART, GRAPH, TABLE, MAPS
DRAW, DRAWING
FOOT, FOOTNOTES
Litigation
Stmn/Produced
Stmn/Trial Exhibit P-11753
Named Person
Wynder
Armitage
Chouroulinkov
Decoulon
Downs
Eaton
Ehrenstorfer, S.
Faccini
Festing
Fischer, K.
Forsbach
Foster
Grimmer
Hauschka
Hoffmann
Homburger
Horter, R.
Kraft
Lazar
Levins
Lynch, C.
Mirand, E.
Parker
Percy
Peto
Pullinger
Richter
Schahl, R.
Schonherr
Tattersall
Ward
Windholz
Operation/Project
Testing done on sidstream smoke at INBIFO
Named Organization
Aesculap
Auergesellschaft
Baker Chemikalien
Bandelin
Beckman Instruments
Buchi
Camag
Carl Platz
Carworth Europe
Diversey
Dr Henning
E Merck
Erba Science
Fachtierarzt Fur Bakteriologie Und Serol
Faust
Fluka
Forma Scientific
Ftr, Fabriques De Tabac Reunies S.A.
Gerhard Teck
German Futtermittelverordnung
H Eggersmann
H Waldner
Hamilton
Hartmann Essen
Henkel Und Cie
Hermle Laborgerate
Hewlett Packard
HRI, Health Research Inst. Roswell Park
International Agency for Research on Cancer (IARC) (WHO cancer research arm)
International Agency for Research on Cancer - The cancer research arm of the WHO. Conducted a multi-center epidemiology study on ETS, initiated in 1988, data collection completed in 1994 and results were published in 1998
Ict Handels
INBIFO, Intitut Fur Biologische Forschung (Philip Morris' secret biological research lab in Europe)
"INBIFO" stands for Institut Fur Biologische Forschung, or Institute for Biological Research. It is located in Germany. Philip Morris acquired Inbifo on June 30, 1971. Its stated mission was "quantitative biological product evaluation" by using "comprehensive toxicological and physiological testing. Major activities are listed as: product evaluation and modifications, product ingredients and ETS-related technical knowledge and smoke components. Inhalation toxicology was a key feature of Inbifo. (Derived from Bates No. 2505235055/5088)
Inst for Cancer Research Philadelphia
Isconlab
Janke Kunkel
K Neuberger
Leybold Heraeus
Linde
Macherey Nagel
Metrawatt
Miele Cie
Natl Toxicology Program
Osram
Packard Instrument
Philips
Rockefeller Inst
Sartorius
Serva Feinbiochemica
Shimadzu
Sigma Chemical
Teletype
Thermo Electron
Vollwood
A Popp
INBIFO, Intitut Fur Biologische Forschung (Philip Morris' secret biological research lab in Europe)
"INBIFO" stands for Institut Fur Biologische Forschung, or Institute for Biological Research. It is located in Germany. Philip Morris acquired Inbifo on June 30, 1971. Its stated mission was "quantitative biological product evaluation" by using "comprehensive toxicological and physiological testing. Major activities are listed as: product evaluation and modifications, product ingredients and ETS-related technical knowledge and smoke components. Inhalation toxicology was a key feature of Inbifo. (Derived from Bates No. 2505235055/5088)
Subject
secondhand smoke
secondhand smoke/health effects
animal research
animal subject
mouse skin painting
Secondhand Smoke/Constituents

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: sgk85e00 Log in for more options!
INBIFO Institut fur biologische Forschung • Koln Dr.med. R. Rylander c/o FABRIQUES DE TABAC REUNIES S.A. Switzerland REPORT P 0500/3068 n imoru - 26.Oct.87 DKU/UBE COPY NO.: Skin Tumorigenicity of Mainstream and Sidestream Whole Smoke Condensate of Standard Reference Cigarette 2R1 80-Week Dermal Application Study with CD1(ICR)BR and B6C3F1 Mice INBIFO Irustiful fiir biologische Forschung GmbH, Fuggerslra6e 3, D-5000 Koln 90 Sitz der Gesellschafl: K&In HR B 367, 29. Oktober 1959 5085 Telefon: Porz (02203) 303-1, Telefax: (02203) 303362, Telex: 8874675 inbi d Institulsleiter und Geschaftsfiihrer: Dr. med. Ulrich Hackenberg
Page 2: sgk85e00 Log in for more options!
INBIFO Institut fiir biologische Forschung • Koln Dr.med. R. Rylander c/o FABRIQUES DE TABAC REUNIES S.A. Switzerland REPORT P 0500/3068 26.Oct.87 DKU/UBE COPY NO.: Skin Tumorigenicity of Mainstream and Sidestream Whole Smoke Condensate of Standard Reference Cigarette 2R1 80-Week Dermal Application Study with CD1(ICR)BR and B6C3F1 Mice Volume 1 INBIFO Institut tiir biologische Forschung GmbH, Fuggerstra0e 3, D-5000 Koln 90 Sitz der Geselischaft: Koln HR B 367, 29. Oktober 1959 5oas Teleton: Porz (02203) 303-1, Telefax: (02203) 303362, Telex: 8874875 inbi d Institutsleiter und Geschaftsfiihrer: Dr. med. Ulrich Hackenberg
Page 3: sgk85e00 Log in for more options!
HEPUK'1' P 0500/3068 UBE1:43RB18 7010 PREFACE This is a part (integrating report and subreport of team Animal Treatment) of the complete report. The complete report consists of an integrating report, which gives a general description of the complete project, and 4 subreports: (1) Analytical Chemistry (2) Animal Treatment (3) Microbiology (4) Pathology Each subreport had been worked out by the respective responsible team. Methods are described in detail in the respective sulbreport but not in the integrating report. Remarks: This part of the report (integrating report and subre- port of team Animal Treatment), including title page, contains 296 pages. 3587
Page 4: sgk85e00 Log in for more options!
INB'IFO Institut fur hiologische For~,chung - Kol'n 3 iriru DR•MED• R• RYLANDER 26•OCT•87 c/o FABRIGIUES DE TABAC REUNIES S•A• DKU/UBE UBE1'41RA3 SW'I TZERLANI) INTEGRATING REPORT ----------------------------------- P 0500/3068 SKIN TUMORIGENICITY OF MAINSTREAM AND SIDESTREAM WHOLE SMOKE CONDENSATE OF STANllNRD R'EFERENCE CIGARRETTE 2R1 8D-WEEK DERMAL APP'LICATION'STUDY WITH CD1(ICR')BR AND B6C3F1 MICE INBIfO kiatGtul fiir biolbyische Forschuny GmbH; FuQyerette8e 3, D•5000 Ktfin 90 Sifz der GeeellschaR: KSIn HR 8 367, 29. Oktober 1959 28.Kwe3 Telefon: Porz (02203) 303-1, Telefax:,(02203) 303362„ Telex:8874675 inbi d Institutsleiler und Gesch&ItBfOhrer•. Dr. med. Ulrie:IrHeckenberg
Page 5: sgk85e00 Log in for more options!
INTEGRATING REPORT P 0500/3068 UBE141RB11 7295 PAGE 0-1 CONTENTS PAGE ABBREVIATIONS 0-3 1 SUMMARY 1.1 Study Concept 1-1 1.2 Objectives 1-1 1.3 Method 1-3 1.4 Results 1-5 1.4.11 Condensates 1-5 1.4.2 General condition and behavior 1-6 1.4.3 Mortality 1-7 1.4.4 Body weight 1-8 1.4.5 Development of macroscopic skin tumors 1-9 ~ 1.4.6 Skin irritations 1-9 1.4.7 Prediction of the microscopic tumor probability in future studies 1-10 1.4.8 Microbiological findings 1-11 1.4.9 Pathological findings 1-12 1.4.10 Conclusions 1-15 FIGURE A: OBJECTIVES 1-2 2 RESPONSIBILITY 2-1 2.1 Project Management 2-1 2.2 Contributing Teams 2-1 't^g5
Page 6: sgk85e00 Log in for more options!
INTEGRATING REPORT P 0500/3068 UBE141RB12 7295 PAGE 0-2' CONTENTS (continued) PAGE' 3 QUALITY ASSURANCE STATEMENT 3-1 INTRODUCTION 4-1 TABLE A: CONCENTRATIONS OF SELECTED COMPOUNDS IN NONFIL- TER CIGARETTE MAINSTREAM SMOKE AND THE RATIO OF THEIR RELATIVE DISTRIBUTION IN SIDESTREAM SMOKE, PARTICULATE PHASE -2 TABLE B: CONCENTRATIONS OF SELECTED COMPOUNDS IN NONFIL- TER CIGARETTE MAINSTREAM SMOKE AND THE RATIO OF THEIR RELATIVE DISTRIBUTION IN SIDESTREAM SMOKE, VAPOR PHASE 4-3 TABLE C: GROUPS AND DOSES 4-8 FIGURE B: CHRONOLOGY 4-10 5 SUBSTANCES EXAMINED 5-1 5.1 Cigarette 5-1 TABLE D: PHYSICAL DATA OF CIGARETTE 2R1 5-2 TABLE E: CONCENTRATION OF SELECTED COMPONENTS IN FILLER, CIGARETTE TYPE 2R1 5-3 TABLE F: YIELD OF SELECTED SMOKE COMPONENTS, CIGARETTE TYPE' 2R1 5-4 5.2 7,12-DimethyTbenz(a)anthracene 5-5 6 STORAGE OF MATERIALS AND RECORDS 6-1 7 REFERENCES 7-1 Remarks: This integrating report, including title page, contains 41 pages. ., q1
Page 7: sgk85e00 Log in for more options!
INTEGRATING REPORT P 0500/3068 UBE141RB10 7295 PAGE 0-3 ABBREVIATIONS (a,b) AC : team Analytical Chemistry DIN : Deutsches Institut fur Normung (German Committee of Standards) • DMBA : 7,1i2-dimethylbenz(a)anthracene DMNA : N-nitrosodimethylamine .GT. : greater than MS : mainstream smoke MTR : macroscopic tumor rate MWSC : mainstream whole smoke condensate MWSC-C : mainstream whole smoke condensate, collected with cool trap MWSC-I : mainstream whole smoke condensate, collected with impaction trap NAB : N-nitrosoanabasine NATB : N-nitrosoanatabine NNK : 4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl),-1-butanone NNN : N-nitrosonornicotine NPY : N-nitrosopyrrolidine NTP : National Toxicology Program PAH : polycyclic aromatic hydrocarbon PT : preliminary title QA : Quality Assurance Unit RT : room temperature SOP : standard operating procedure SS : sidestream smoke SWSC : sidestream whole smoke condensate SWSC-I : sidestream whole smoke condensate, collected with impaction trap TPA : 12-O-tetradecanoylphorbol-13-acetate, synomym: 4-beta-phorbol-12-myristate-13-acetate TPM : total particulate matter, determined gravimetrically WS : whole smoke WSC : whole smoke condensate WSC-C : whole smoke condensate, collected with cool trap WSC-I : whole smoke condensate, collected with impaction trap (a) in addition to those, which are explained immediately on the same page (b) Units are given: in accordance with SI-norms (Systeme International d'Unites). T~ lc.
Page 8: sgk85e00 Log in for more options!
LN1'EGkAY'ING REPORT' P 0500/3068 UBE141RA4 7295 PAGE 1-1 1 SUMMARY 1.1 Study Concept In the present chronic study the skin tumorigenicity of WHOLE SMOKE CONDENSATE (WSC), of MAINSTREAM and SIDESTREAM SMOKE (MS and SS), of the standard reference cigarette 2R1 was determined after applications to the dorsal skin of female CD1 mice for 80 weeks. In addition, mainstream condensate was assayed on female B6C3F1 mice (a). WSC was applied to both mouse strains without and with pretreatment of a single dose (200 nanomols per mouse) of 7,12- dimethylbenz(a)anthracene (DMBA). This dose is thought to initiate but not to promote all sites in the application area which can be promoted to produce skin tumors subsequently. Therefore the pro- moting activity of the 2 WSC types can be derived from the skin tumorigenicity after DMBA pretreatment. 1.2 Objectives The objectives (b) of the study were the following: (1), the comparison of the skin tumorigenicity (tumor probabili- ty, multiplicity, and malignancy) of MWSC-I and SWSC-I of the standard reference cigarette 2R1; (2) the influence of the pretreatment of mice with an initiating dose of DMBA on the skin tumorigenicity of MWSC-I and SWSC-I; (3) the comparison of CD1 and B6C3F1 mice with respect to their sensitivity to the skin tumorigenicity of MWSC-I; (4) the comparison of the skin tumorigenicity of MWSC-I stored at 4 and -75 degrees centigrade before application. (a) hybrid strain used by the National Toxicology Program (N'TP) (USA) for carcinog~enesis studies including dermal application (b) see FIGURE A 'i995
Page 9: sgk85e00 Log in for more options!
INTEGRAZ'ING REPORT P 0500/3120 UBE141RA17 72'95 M PAGE 1-2 CD1 (MWSC-I) (3) B6C3F1 (MWSC-I) 4 °C ~IWSC-I (CD1 ) (4) -75 ~C MWSC-I (CD1) FIGURE A <: ---/ (2). ~------~ (2) /-------~ MWSC-I plus DMBA (CD1), (1) SWSC-I plus DMBA (CDI) CD 1 (M'IcSC-I pl u5 DMBA ) (3) B6C3F1 (MWSC-I plus DMBA) OBJECTIVES
Page 10: sgk85e00 Log in for more options!
INTEGRATING REPORT P 0500/3068 UBE141RA5 7295 PAGE 1-3 1.3 Method For the preparation of the application solution, MWSC and SWSC were collected in impaction traps (MWSC-I and SWSC-I), processed, and suspended in acetone. Concentrations of nicotine, water, hydrogen-ions, selected nitrosamines, catechol, selected poly- cyclic aromatic hydrocarbons, and volatile components of the WSC-I were regularly determined in either the processed condensate or the application solution. The application solutions were stored at -75 degrees centigrade until application except for 3 groups. These groups received MWSC-I stored at 4 degrees centigrade as in all previous INBIFO skin painting studies. 2625 mice, i. e., 1785 (a) outbred female CD1 mice from Charles River, France and 840 female B6C3F1 mice from Charles River, USA reared under specific pathogen free conditions were kept in barriered animal laboratory units. 7 mice each were kept in polycarbonate cages with granulated, softwood bedding. The mice were fed an autoclaved, fortified diet and watered with tap water ad libitum. The room temperature was 22 + 2 degrees centigrade, the relative humidity 55 + 10 percent and the light cycle 12 hours : 12 hours. The hair of the application area was shaved prior to the application of DMBA, before the 1st application of WSC-I, and subsequently 1 time per week and additionally for individual mice which showed increased hair growth. Microbiological screening of the mice as well as bacteriological controls of the laboratory unit, animal diet, drinking water, cage bedding material, and laboratory staff were performed. Selected pesticides, aflatoxins, and heavy metals were determined in the diet and in the bedding, material. Diet and bedding material were only used when the residues were below the tolerance levels. The 2625 mice were randomly allocated to 25 groups (105 mice per group)'i. At the age of 36 + 2 days the mice of several groups re- ceived a single dermal application of 200 nanomols DMBA (equiva- (a) mice for microbiological analysis not included ,. jr

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: